Jade Biosciences Income Statement (2020-2026) | JBIO

Income Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating items
Research & Development (Quarter)
4.33M3.42M5.05M7.25M8.36M10.78M12.22M13.49M16.03M16.88M17.81M20.08M0.08M13.58M31.23M20.02M22.55M22.01M1.50M36.05M
Wages, Salaries and Other (Quarter)
0.01M2.25M1.71M1.93M3.58M-1.33M5.30M
Selling, General & Administrative (Quarter)
1.45M2.78M3.22M3.76M3.85M3.37M3.63M4.15M4.30M4.48M4.25M4.54M0.51M1.38M4.30M3.36M5.23M5.39M6.44M7.39M
Restructuring Costs (Quarter)
0.18M
Other Operating Expenses (Quarter)
-0.18M27.04M
Operating Expenses (Quarter)
5.77M6.20M8.27M11.02M12.21M14.15M15.85M17.64M20.34M21.37M22.07M24.62M0.59M14.96M35.54M23.38M27.78M27.40M34.98M43.45M
Operating Income (Quarter)
-5.77M-6.20M-8.27M-11.02M-12.21M-14.15M26.56M-17.64M-20.34M-21.37M43.51M-24.62M-0.59M-14.96M-9.87M-23.38M-27.78M-27.40M-34.98M-43.45M
EBIT (Quarter)
-5.77M-6.20M-8.27M-11.02M-12.21M-14.15M26.56M-17.64M-20.34M-21.37M43.51M-24.62M-0.59M-14.96M-9.87M-23.38M-27.78M-27.40M-34.98M-43.45M
Non-operating items
Non Operating Investment Income (Quarter)
0.04M
Interest & Investment Income (Quarter)
0.00M0.02M0.05M0.11M0.23M0.56M0.93M1.12M1.31M1.80M1.71M1.44M0.39M1.16M0.61M1.83M2.25M3.08M3.10M
Other Non Operating Income (Quarter)
-0.00M0.02M0.07M0.11M-0.01M0.00M1.75M1.12M1.31M0.00M-0.00M1.39M-0.03M0.02M-0.01M
Non Operating Income (Quarter)
-0.00M0.02M0.05M0.11M-0.01M0.56M1.75M1.12M1.31M0.00M-3.82M-0.00M-1.31M-14.79M-4.36M-0.03M-13.78M-0.01M
Net income details
EBT (Quarter)
-5.78M-6.18M-8.22M-10.91M-11.99M-13.59M27.49M-16.52M-19.02M-19.56M45.22M-23.19M-0.60M-14.58M-46.98M-38.17M-25.95M-25.15M-31.89M-40.35M
Tax Provisions (Quarter)
0.02M
Profit After Tax (Quarter)
-5.78M-6.18M-8.22M-10.91M-11.99M-13.59M-15.02M-16.52M-19.02M-19.56M-20.41M-23.19M-0.59M-16.28M-46.98M-38.17M-32.13M-25.18M-31.93M-40.37M
Income from Continuing Operations (Quarter)
-5.78M-6.18M-8.22M-10.91M-11.99M-13.59M27.49M-16.52M-19.02M-19.56M45.22M-23.19M-0.60M-14.58M-46.98M-38.17M-25.95M-25.15M-31.89M-40.37M
Consolidated Net Income (Quarter)
-5.78M-6.18M-8.22M-10.91M-11.99M-13.59M27.49M-16.52M-19.02M-19.56M45.22M-23.19M-0.60M-14.58M-46.98M-38.17M-25.95M-25.15M-31.89M-40.37M
Income towards Parent Company (Quarter)
-5.78M-6.18M-8.22M-10.91M-11.99M-13.59M27.49M-16.52M-19.02M-19.56M45.22M-23.19M-0.60M-14.58M-46.98M-38.17M-25.95M-25.15M-31.89M-40.37M
Net Income towards Common Stockholders (Quarter)
-5.78M-6.18M-8.22M-10.91M-11.99M-13.59M27.49M-16.52M-19.02M-19.56M45.22M-23.19M-0.60M-14.58M-46.98M-38.17M-25.95M-25.15M-31.89M-40.37M
Additional items
EPS (Basic) (Quarter)
-23.80-0.26-0.07-0.45-0.49-0.56-0.61-0.67-0.76-0.71-0.74-0.83-0.19-5.16-14.89-12.10-0.86-0.48-0.11-0.57
EPS (Weighted Average and Diluted) (Quarter)
-0.26-0.07-0.45-0.49-0.56-0.61-0.67-0.76-0.71-0.74-0.83-0.19-5.16-14.89-12.10-0.86-0.48-0.11-0.57
Shares Outstanding (Weighted Average) (Quarter)
0.24M8.18M12.29M24.41M24.41M24.45M24.47M24.78M24.97M27.64M26.33M27.80M3.16M3.16M3.16M3.16M28.43M39.58M31.36M57.78M
Shares Outstanding (Diluted Average) (Quarter)
8.18M12.29M24.41M24.41M24.45M24.47M24.78M24.97M25.87M26.33M27.80M3.16M3.16M3.16M3.16M28.43M39.58M31.36M57.78M
EBITDA (Quarter)
-5.78M-6.18M-8.28M-11.49M-12.13M-13.57M-14.72M-16.25M-19.05M-19.59M-19.95M-23.46M-0.59M-16.87M-46.98M-38.17M-32.16M-25.12M-31.83M-40.84M
Interest Expenses (Quarter)
0.00M-0.00M0.01M0.00M0.00M0.00M0.01M
Shares Outstanding (Quarter)
0.24M24.41M24.41M24.41M24.42M24.51M24.72M24.82M27.60M27.65M27.76M27.90M3.67M3.67M3.67M3.67M32.63M32.63M49.32M49.35M
Tax Rate (Quarter)
-0.04